Evidence map›Paper›PMID 28767733›Full record

Observational studyPloS one2017

Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.

Lei Liu, Ying He, Ge Ge, Lei Li, Ping Zhou, Yihan Zhu, Huairong Tang, Yan Huang, Weimin Li, Li Zhang

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Standardized uptake valueCancer medicine · 2024
    Observational
  9. Evaluation of prognostic risk factors of triple-negative breast cancer withFrontiers in cell and developmental biology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lei LiuLaboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Ying HeWest China Medical School, Sichan University, Cheng Du, Sichuan Province, China.
Ge GeWest China Medical School, Sichan University, Cheng Du, Sichuan Province, China.
Lei LiDepartment of Respiratory, West China Hospital, Sichuan University, Cheng Du, Sichuan Province, China.
Ping ZhouDepartment of Respiratory, West China Hospital, Sichuan University, Cheng Du, Sichuan Province, China.
Yihan ZhuLaboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Huairong TangHealth Management Center, West China Hospital, Sichuan University, Cheng Du, China.
Yan HuangHealth Management Center, West China Hospital, Sichuan University, Cheng Du, China.
Weimin LiDepartment of Respiratory, West China Hospital, Sichuan University, Cheng Du, Sichuan Province, China.
Li ZhangLaboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
West China Hospital of Sichuan University · CNSichuan University · CNWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCirculating molecules play important roles in lung cancer diagnosis. In addition, plasma lactate dehydrogenase (LDH) and creatine kinase (CK) have been shown to be closely related to tumor progression in breast cancer, prostate cancer, and colonel cancer. However, the relationships between LDH and CK levels with metastasis occurrence and the survival status of lung cancer patients remain unclear. EXPERIMENTAL

designA total of 1142 lung cancer patients were enrolled in this study and were separated into negative or positive groups, according to the plasma levels of CK or LDH. Patients in both groups were assessed for clinical characteristics, metastasis occurrence, and survival status. The Cox regression model was then introduced to confirm whether CK and LDH could act as independent factors for predicting a poor prognosis.

resultsThe results indicated that CK had a close relationship with bone (p < 0.05) and lymph node (p < 0.05) metastases. In addition, LDH was strongly related with bone (p < 0.05), adrenal gland (p < 0.05), and lymph node (p < 0.05) metastases. CK and LDH were also correlated with the survival status of the lung cancer patients (all p < 0.001). According to specific histological classification analysis, it was found that CK was closely related to the survival status of adenocarcinoma (ADC) and squamous cell carcinoma (SCC) patients, while LDH was only correlated with that of ADC patients. Cox regression analysis confirmed that CK and LDH could act as independent factors for predicting a poor prognosis in ADC but not SCC patients.

conclusionsFor the first time, our study confirmed the role of CK in metastasis occurrence and the survival status of lung cancer patients. In addition, it also demonstrated that CK and LDH could be used as independent factors to predict a poor prognosis in ADC patients. The identification of CK and LDH will play important roles in lung cancer diagnosis and poor outcome prediction in the future.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAdultAgedBone NeoplasmsCarcinoma, Squamous CellCreatine KinaseFemaleHumansL-Lactate DehydrogenaseLung NeoplasmsLymphatic MetastasisMaleMiddle AgedPrognosisRegression AnalysisCreatine KinaseL-Lactate Dehydrogenase

Identifiers

PMID28767733
PMCPMC5540491
OpenAlexW2742120648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.